3DBio Therapeutics Announces Appointment of Sol Barer, Ph.D. and Kevin Slawin, M.D. to Board of Directors
Leave reply:
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Follow Kairos Ventures on LinkedIn
Subscribe to Kairos News
Recent Posts
- Vivodyne Launches the World’s Largest Human Biological Datacenter to Train the First World Model of Human Biology
- AI-powered methods shake up animal testing
- Melior Discovery Selected as Preclinical CRO to Support Linnaeus Therapeutics’ ARPA-H PROSPR Program
- Linnaeus Therapeutics Announces Selection of LNS8801 into the National Institute on Aging Interventions Testing Program
- Northwestern Study Looks at How Megalibraries Could Outperform Self-Driving Labs When it Comes to Materials Discovery